Patient Survey Reveals Significant Physical Burden of Psoriatic Disease
Researchers sought to assess patients’ understanding of the systemic nature of psoriatic disease.
Researchers sought to assess patients’ understanding of the systemic nature of psoriatic disease.
Researchers evaluated the association between biological therapy and the time to incident inflammatory psoriatic arthritis.
Researchers assessed the accuracy of a traditional statistical risk factor-based model versus machine learning in predicting the 5-year probability of biologic discontinuation.
Researchers assessed whether biologics reduce the incidence of psoriatic arthritis among patients with psoriasis.
A 66-year-old woman presents with a flare of a chronic skin condition that has been treated with numerous therapies over the past 20 years.
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
People with psoriasis have double the odds of celiac disease vs people without psoriasis.
Study investigators assessed the risk of infection among pediatric patients undergoing treatment with methotrexate, etanercept, or ustekinumab for psoriasis.
A team of investigators sought to determine whether alcohol consumption or cigarette smoking contributed to the risk of developing psoriasis among postmenopausal women.
Investigators sought to determine what effect the COVID-19 pandemic had on patient preference for biologic treatment for psoriasis.